University of Maryland Rheumatology

Topics

• Systemic Lupus Erythematosus Research 45
• Otitis Media and Relapsing Polychondritis 43
• Rheumatoid Arthritis Research and Therapies 11
• Multiple Sclerosis Research Studies 9
• Spondyloarthritis Studies and Treatments 9
• Complement system in diseases 8
• Osteoarthritis Treatment and Mechanisms 8
• Renal cell carcinoma treatment 5
• Bone health and osteoporosis research 4
• Liver Disease Diagnosis and Treatment 4
• Mesenchymal stem cell research 4
• Pulmonary Hypertension Research and Treatments 4

Most cited

1. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.

   JAMA · 2023 · 204 citations · Marcela Ferrada

2. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.

   Blood · 2022 · 178 citations · Marcela Ferrada

3. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.

   Blood advances · 2021 · 207 citations · Marcela Ferrada

4. Advances in the management of systemic lupus erythematosus.

   BMJ (Clinical research ed.) · 2023 · 106 citations · Ashira D. Blazer

5. Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis.

   Blood · 2022 · 161 citations · Marcela Ferrada

6. Spectrum of clonal hematopoiesis in VEXAS syndrome.

   Blood · 2023 · 123 citations · Marcela Ferrada

7. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.